Latest update from ReNeuron stem cell trial
ReNeuron has announced an encouraging update on the progress of its Phase 1/2 trial of a stem cell-based therapy for retinitis pigmentosa, describing the most recent results as a “clear …
Continue reading “Latest update from ReNeuron stem cell trial”
Recognition for Retina UK volunteer at Helplines Partnerships Awards
Congratulations and a huge well done to Elizabeth Baio who was awarded 3rd place in the Volunteer of the Year awards at the Helplines Partnership Conference on Wednesday 6 November. …
Continue reading “Recognition for Retina UK volunteer at Helplines Partnerships Awards”
Worksop’s Got Talent 2019
More than 700 people came together for an evening of entertainment and fundraising for Retina UK at Worksop’s Got Talent 2019. The fourth event of its kind, Worksop’s Got Talent …
Retina UK Tandem Cycle Challenge 2019
On 11 October, a group arrived in Whitley Bay, eagerly anticipating the weekend’s adventure. They had come together to take part in the Retina UK Tandem Cycle Challenge, a 100 …
Informative and positive first Professionals’ Conference from Retina UK
Overwhelming positive feedback has been received from the 180 delegates who joined us for our first Professionals’ Conference. The education, health and social-care professionals who attended the event on Friday …
Continue reading “Informative and positive first Professionals’ Conference from Retina UK”
Press release: Retina UK publishes unique insight into the experiences of people with inherited retinal conditions
Evidence of the real-life experiences, challenges and expectations of almost 1,000 people affected by inherited sight loss conditions have been published by national sight loss charity Retina UK. The charity …
Study reveals impact of inherited sight loss on wellbeing and productivity
The findings of a pilot study into the burden of Inherited Retinal Disease (IRD) on the wellbeing and productivity of those affected have today been announced at EURetina in Paris. …
Continue reading “Study reveals impact of inherited sight loss on wellbeing and productivity”
Press release: NICE approves first treatment on the NHS for an inherited retinal dystrophy
Today the National Institute for Health and Care Excellence (NICE) has recommended Luxturna (voretigene neparvovec) for use in the NHS in England, making it the first available treatment for an …
NICE approves first treatment on the NHS for an inherited retinal dystrophy
Today the National Institute for Health and Care Excellence (NICE) has recommended Luxturna (voretigene neparvovec) for use in the NHS in England, making it the first available treatment for an …
Continue reading "NICE approves first treatment on the NHS for an inherited retinal dystrophy"
ProQR Announces Clearance of IND to Start Clinical Trial
ProQR Therapeutics announced on Monday 12 August that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for QR-1123, which is the first investigational medicine to …
Continue reading “ProQR Announces Clearance of IND to Start Clinical Trial”
Awaiting funding decision for Luxturna
In the last issue of Look Forward, we reported that the gene therapy Luxturna had won European regulatory approval for the treatment of a particular type of inherited sight loss. …
Hope to Seaview 2019
Thank you to Retina UK Trustee Colin McArthur, his wife Linda and everyone who took part or donated to Hope to Seaview on the Isle of Wight on 9 June. …